Enhancing myocardial repair with CardioClusters

Area of Science:

• Regenerative Medicine
• Cardiovascular Research
• Biotechnology

Background:

• Cellular therapy for heart failure shows limited progress in structural and functional recovery.
• Next-generation therapies involve combinatorial cell populations for synergistic effects.
• Existing methods face challenges in cell retention and maximizing reparative activity.

Purpose of the Study:

• To develop and evaluate a novel 3D scaffold-free microenvironment for cardiac cell therapy.
• To assess the therapeutic potential of engineered combinatorial cardiac cell populations.
• To improve cell retention, vascularization, and cardiac function post-myocardial infarction.

Main Methods:

• Isolation and co-culture of mesenchymal stem cells (MSCs), endothelial progenitor cells (EPCs), and c-Kit+ cardiac interstitial cells (cCICs).
• Formation of 3D scaffold-free microenvironments termed CardioClusters.
• Intramyocardial delivery of CardioClusters in a murine myocardial infarction model.
• scRNA-Seq profiling to analyze CardioCluster gene expression.
• Assessment of cardiac function, cell retention, and capillary density over 20 weeks.

Main Results:

• CardioClusters spontaneously formed 3D structures with maximized cell interaction and controlled ratios.
• scRNA-Seq revealed CardioClusters express stem cell-relevant factors and native cardiac cell transcriptomes.
• Intramyocardial delivery significantly improved cell retention and capillary density.
• CardioClusters preserved cardiomyocyte size and demonstrated long-term cardiac function recovery in vivo.
• Preclinical models showed mitigation of cardiomyopathic damage.

Conclusions:

• CardioClusters represent a promising scaffold-free 3D platform for cardiac cell therapy.
• This approach enhances cell retention and promotes cardiac tissue regeneration.
• CardioCluster therapy offers a viable strategy for mitigating heart failure damage and improving cardiac function.